Name
Abstract | ||
|---|---|---|
The paper addresses the development of an artificial pancreas for the treatment of Type 1 Diabetes Mellitus, and more precisely the design of a control law for insulin delivery. As opposed to current existing solutions, the proposed approach is patient-independent, so it tackles the variability of the patients. Robust margins and worst-case performance are also established by means of the H∞<... |
Year | DOI | Venue |
|---|---|---|
2021 | 10.23919/ECC54610.2021.9654888 | 2021 European Control Conference (ECC) |
Keywords | DocType | ISBN |
Robust control,Medical treatment,Europe,Regulation,Biology,Diabetes,Delays | Conference | 978-9-4638-4236-5 |
Citations | PageRank | References |
0 | 0.34 | 0 |
Authors | ||
12 | ||
Name | Order | Citations | PageRank |
|---|---|---|---|
| Louis Cassany | 1 | 0 | 0.34 |
| David Gucik-Derigny | 2 | 0 | 0.34 |
| Jérôme Cieslak | 3 | 0 | 0.34 |
| David Henry | 4 | 0 | 0.34 |
| Roberto Franco | 5 | 0 | 2.03 |
| Alejandra Ferreira de Loza | 6 | 0 | 0.68 |
| Hector Ríos | 7 | 0 | 0.34 |
| Loïc Olçomendy | 8 | 0 | 0.34 |
| Antoine Pirog | 9 | 0 | 0.34 |
| Yannick Bornat | 10 | 0 | 0.34 |
| Sylvie Renaud | 11 | 0 | 0.34 |
| Bogdan Catargi | 12 | 0 | 0.34 |